127 related articles for article (PubMed ID: 10789839)
1. Placebo-controlled evaluation of the irritant potential of tacalcitol (1a,24-dihydroxyvitamin D3) in healthy volunteers.
Schlotmann K; Ortland C; Neumann NJ; Ruzicka T; Lehmann P
Contact Dermatitis; 2000 May; 42(5):260-3. PubMed ID: 10789839
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
Ruzicka T; Trompke C
Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
[TBL] [Abstract][Full Text] [Related]
3. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
4. Profile of clinical efficacy and safety of topical tacalcitol.
Leone G; Pacifico A
Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
[TBL] [Abstract][Full Text] [Related]
6. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis.
Kawaguchi M; Mitsuhashi Y; Kondo S
J Dermatol; 2003 Nov; 30(11):801-4. PubMed ID: 14684937
[TBL] [Abstract][Full Text] [Related]
9. Current experience with tacalcitol ointment in the treatment of psoriasis.
Gollnick H; Menke T
Curr Med Res Opin; 1998; 14(4):213-8. PubMed ID: 9891193
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
[TBL] [Abstract][Full Text] [Related]
12. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.
Queille-Roussel C; Duteil L; Parneix-Spake A; Arsonnaud S; Rizova E
Eur J Dermatol; 2001; 11(3):219-24. PubMed ID: 11358728
[TBL] [Abstract][Full Text] [Related]
13. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.
Barker JN; Ashton RE; Marks R; Harris RI; Berth-Jones J
Br J Dermatol; 1999 Aug; 141(2):274-8. PubMed ID: 10468799
[TBL] [Abstract][Full Text] [Related]
14. Effect of a topical corticosteroid, a retinoid and a vitamin D3 derivative on sodium dodecyl sulphate induced skin irritation.
Le TK; De Mon P; Schalkwijk J; van der Valk PG
Contact Dermatitis; 1997 Jul; 37(1):19-26. PubMed ID: 9255481
[TBL] [Abstract][Full Text] [Related]
15. A case of subcorneal pustular dermatosis treated with tacalcitol (1alpha,24-dihydroxyvitamin D3).
Kawaguchi M; Mitsuhashi Y; Kondo S
J Dermatol; 2000 Oct; 27(10):669-72. PubMed ID: 11092273
[TBL] [Abstract][Full Text] [Related]
16. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
[TBL] [Abstract][Full Text] [Related]
17. Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury.
Mommers JM; ter Meulen AC; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 1999; 12(4):174-81. PubMed ID: 10420137
[TBL] [Abstract][Full Text] [Related]
18. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream.
Nakayama J
Eur J Dermatol; 2000; 10(7):528-32. PubMed ID: 11056423
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
Syuto T; Ishibuchi H; Sogabe Y; Yokoyama Y; Ishikawa O
Dermatol Online J; 2008 Feb; 14(2):2. PubMed ID: 18700105
[TBL] [Abstract][Full Text] [Related]
20. Topical D-vitamins: multiparametric comparison of the irritant potential of calcipotriol, tacalcitol and calcitriol in a hairless guinea pig model.
Fullerton A; Serup J
Contact Dermatitis; 1997 Apr; 36(4):184-90. PubMed ID: 9165200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]